Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2009

Open Access 01-12-2009 | Research

Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil

Authors: Marilia B Gomes, Daniel Giannella-Neto, Manuel Faria, Marcos Tambascia, Reine M Fonseca, Rosangela Rea, Geisa Macedo, João Modesto-Filho, Helena Schmid, Alcina V Bittencourt, Saulo Cavalcanti, Nelson Rassi, Hermelinda Pedrosa, Sergio A Dib

Published in: Diabetology & Metabolic Syndrome | Issue 1/2009

Login to get access

Abstract

According to Brazilian National Data Survey diabetes is the fifth cause for hospitalization and is one of the ten major causes of mortality in this country.

Aims

to stratify the estimated cardiovascular risk (eCVR) in a population of type 2 diabetics (T2DM) according to the Framingham prediction equations as well as to determine the association between eCVR with metabolic and clinical control of the disease.

Methods

From 2000 to 2001 a cross-sectional multicenter study was conducted in 13 public out-patients diabetes/endocrinology clinics from 8 Brazilian cities. The 10-year risk of developing coronary heart disease (CHD) was estimated by the prediction equations described by Wilson et al (Circulation 1998). LDL equations were preferably used; when patients missed LDL data we used total cholesterol equations instead.

Results

Data from 1382 patients (59.0% female) were analyzed. Median and inter-quartile range (IQ) of age and duration of diabetes were 57.4 (51-65) and 8.8 (3-13) years, respectively without differences according to the gender. Forty-two percent of these patients were overweight and 35.4% were obese (the prevalence of higher BMI and obesity in this T2DM group was significantly higher in women than in men; p < 0.001). The overall estimated eCVR in T2DM patients was 21.4 (13.5-31.3). The eCVR was high (> 20%) in 738 (53.4%), intermediate in 202 (14.6%) and low in 442 (32%) patients. Men [25.1(15.4-37.3)] showed a higher eCVR than women [18.8 (12.4-27.9) p < 0.001]. The most common risk factor was high LDL-cholesterol (80.8%), most frequently found in women than in men (p = 0.01). The median of risk factors present was three (2-4) without gender differences. Overall we observed that 60 (4.3%) of our patients had none, 154(11.1%) one, 310 (22.4%) two, 385 (27.9%) three, 300 (21.7%) four, 149 (10.5%) five and six, (2%) six risk factors. A higher eCVR was noted in overweight or obese patients (p = 0.01 for both groups). No association was found between eCVR with age or a specific type of diabetes treatment. A correlation was found between eCVR and duration of diabetes (p < 0.001), BMI (p < 0.001), creatinine (p < 0.001) and triglycerides levels (p < 0.001) but it was not found with HbA1c, fasting blood glucose and post-prandial glucose. A higher eCVR was observed in patients with retinopathy (p < 0.001) and a tendency in patients with microalbuminuria (p = 0.06). Conclusion: our study showed that in this group of Brazilian T2DM the eCVR was correlated with the lipid profile and it was higher in patients with microvascular chronic complications. No correlation was found with glycemic control parameters. These data could explain the failure of intensive glycemic control programs aiming to reduce cardiovascular events observed in some studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global prevalences of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H: Global prevalences of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
3.
go back to reference Malerbi DA, Franco LJ, The Brazilian Cooperative Group on the Study of Diabetes Prevalence: Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban brazilian population aged 30-69 yr. Diabetes Care. 1992, 15: 1509-1516. 10.2337/diacare.15.11.1509.CrossRefPubMed Malerbi DA, Franco LJ, The Brazilian Cooperative Group on the Study of Diabetes Prevalence: Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban brazilian population aged 30-69 yr. Diabetes Care. 1992, 15: 1509-1516. 10.2337/diacare.15.11.1509.CrossRefPubMed
4.
go back to reference Torquato MTCG, Montenegro RM, Viana LAL, Souza RAGH, Lanna CM, Lucas JCB: Prevalence of diabetes mellitus, impaired glucose tolerance and cardiovascular risk factors in the urban adult population of Ribeirão Preto. Diabetes Research and Clinical Practice. 2000, 50 (suppl 1): S140-10.1016/S0168-8227(00)81934-8.CrossRef Torquato MTCG, Montenegro RM, Viana LAL, Souza RAGH, Lanna CM, Lucas JCB: Prevalence of diabetes mellitus, impaired glucose tolerance and cardiovascular risk factors in the urban adult population of Ribeirão Preto. Diabetes Research and Clinical Practice. 2000, 50 (suppl 1): S140-10.1016/S0168-8227(00)81934-8.CrossRef
6.
go back to reference Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA. 1998, 281: 1291-1297. 10.1001/jama.281.14.1291.CrossRef Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA. 1998, 281: 1291-1297. 10.1001/jama.281.14.1291.CrossRef
7.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth : Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trail. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed Stamler J, Vaccaro O, Neaton JD, Wentworth : Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trail. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed
8.
go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease insubjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. NEJM. 1998, 339: 229-234. 10.1056/NEJM199807233390404.CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease insubjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. NEJM. 1998, 339: 229-234. 10.1056/NEJM199807233390404.CrossRefPubMed
9.
go back to reference American Diabetes Association: Economic Costs of diabetes in the U.S. in 2007. Diabetes Care. 2008, 31: 596-615. 10.2337/dc08-9017.CrossRef American Diabetes Association: Economic Costs of diabetes in the U.S. in 2007. Diabetes Care. 2008, 31: 596-615. 10.2337/dc08-9017.CrossRef
10.
go back to reference Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation. 1998, 97: 1837-47.CrossRefPubMed Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation. 1998, 97: 1837-47.CrossRefPubMed
11.
go back to reference Friedwald WT, Levy R, Fredrickson DS: Estimations of serum low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502. Friedwald WT, Levy R, Fredrickson DS: Estimations of serum low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.
13.
go back to reference Price HC, Coleman RL, Stevens RJ, Holman RR: Impact of using a non-diabetic specific risk calculator on eligibility for statin therapy in type 2 diabetes. Diabetologia. 2009, 1231-5. Price HC, Coleman RL, Stevens RJ, Holman RR: Impact of using a non-diabetic specific risk calculator on eligibility for statin therapy in type 2 diabetes. Diabetologia. 2009, 1231-5.
14.
go back to reference Wei M, Gaskill SP, Haffner SM, Stern MP: Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality, The San Antonio Heart Study. Diabetes Care. 1998, 21: 1167-1172. 10.2337/diacare.21.7.1167.CrossRefPubMed Wei M, Gaskill SP, Haffner SM, Stern MP: Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality, The San Antonio Heart Study. Diabetes Care. 1998, 21: 1167-1172. 10.2337/diacare.21.7.1167.CrossRefPubMed
15.
go back to reference Hu G, Jousilahti P, Quio Q, Katoh S, Tuomilehto J: Sex fifferences in cardiovascular and total mortality among diabetic an non-diabetic individuals with or without history of myocardial infarction. Diabetologia. 2005, 48: 856-861. 10.1007/s00125-005-1730-6.CrossRefPubMed Hu G, Jousilahti P, Quio Q, Katoh S, Tuomilehto J: Sex fifferences in cardiovascular and total mortality among diabetic an non-diabetic individuals with or without history of myocardial infarction. Diabetologia. 2005, 48: 856-861. 10.1007/s00125-005-1730-6.CrossRefPubMed
16.
go back to reference Kanaya AM, Grady D, Barret-Connor E: Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus:a meta-analysis. Arch Intern Med. 2002, 162: 1737-1745. 10.1001/archinte.162.15.1737.CrossRefPubMed Kanaya AM, Grady D, Barret-Connor E: Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus:a meta-analysis. Arch Intern Med. 2002, 162: 1737-1745. 10.1001/archinte.162.15.1737.CrossRefPubMed
17.
go back to reference Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E: Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care. 2005, 28: 514-520. 10.2337/diacare.28.3.514.CrossRefPubMed Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E: Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care. 2005, 28: 514-520. 10.2337/diacare.28.3.514.CrossRefPubMed
18.
go back to reference Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET: Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care. 1998, 28: 1258-1265. 10.2337/diacare.21.8.1258.CrossRef Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET: Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care. 1998, 28: 1258-1265. 10.2337/diacare.21.8.1258.CrossRef
19.
go back to reference Lee ET, Howard BV, Wang W, Welty TK, Galloway JM, Best LG, Fabsitz RR, Zhang Y, Yeh J, Devereux RB: Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria. The Strong Heart Study. Circulation. 2006, 113: 2897-2905. 10.1161/CIRCULATIONAHA.105.593178.CrossRefPubMed Lee ET, Howard BV, Wang W, Welty TK, Galloway JM, Best LG, Fabsitz RR, Zhang Y, Yeh J, Devereux RB: Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria. The Strong Heart Study. Circulation. 2006, 113: 2897-2905. 10.1161/CIRCULATIONAHA.105.593178.CrossRefPubMed
20.
go back to reference Yang X, Ma RC, So WY, Ko GT, Kong AP, Lam CW, Ho C-S, Cockram CS, Wong VC, tong PC, Chan JC: Impacts of chronic kidney disease and albuminuria on associations between coronary artery disease and its traditional risk factors in type 2 diabetic patients-the Hong Kong diabetes registry. Cardiovascular Diabetology. 2007, 6: 37-10.1186/1475-2840-6-37.PubMedCentralCrossRefPubMed Yang X, Ma RC, So WY, Ko GT, Kong AP, Lam CW, Ho C-S, Cockram CS, Wong VC, tong PC, Chan JC: Impacts of chronic kidney disease and albuminuria on associations between coronary artery disease and its traditional risk factors in type 2 diabetic patients-the Hong Kong diabetes registry. Cardiovascular Diabetology. 2007, 6: 37-10.1186/1475-2840-6-37.PubMedCentralCrossRefPubMed
21.
go back to reference Aguilar D, Hallman DM, Piller LB, Klein BE, Klein R, Devereux RB, Arnett DK, Gonzalez VH, Hanis CL: Adverse association between diabetic retinopathy and cardiac structure and function. Am Heart J. 2009, 157: 563-8. 10.1016/j.ahj.2008.10.019.PubMedCentralCrossRefPubMed Aguilar D, Hallman DM, Piller LB, Klein BE, Klein R, Devereux RB, Arnett DK, Gonzalez VH, Hanis CL: Adverse association between diabetic retinopathy and cardiac structure and function. Am Heart J. 2009, 157: 563-8. 10.1016/j.ahj.2008.10.019.PubMedCentralCrossRefPubMed
22.
go back to reference Wong N, Po JR, Frankln SS, L'Italien GJ, Kamath TV, Williams GR: Preventing coronary events by optimal control of blood pressure an lipids in patients with the metabolic syndrome. Am J Cardiol. 2003, 91: 1421-1426. 10.1016/S0002-9149(03)00392-8.CrossRefPubMed Wong N, Po JR, Frankln SS, L'Italien GJ, Kamath TV, Williams GR: Preventing coronary events by optimal control of blood pressure an lipids in patients with the metabolic syndrome. Am J Cardiol. 2003, 91: 1421-1426. 10.1016/S0002-9149(03)00392-8.CrossRefPubMed
23.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth : Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trail. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed Stamler J, Vaccaro O, Neaton JD, Wentworth : Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trail. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed
24.
go back to reference Gomes MB, Gianella D, Faria M, Tambascia M, Fonseca R, Rea R, Macedo G, Filho JM, Schimid H, Bittencourt AV, Cavalcanti S, Rassi N, Pedrosa H, e Dib SA: Prevalence of patients with diabetes type 2 within the targets of care guidelines in daily clinical practice: A multicenter study of type 2 diabetes in Brazil. The Review of Diabetic Studies. 2006, 3: 73-78. Gomes MB, Gianella D, Faria M, Tambascia M, Fonseca R, Rea R, Macedo G, Filho JM, Schimid H, Bittencourt AV, Cavalcanti S, Rassi N, Pedrosa H, e Dib SA: Prevalence of patients with diabetes type 2 within the targets of care guidelines in daily clinical practice: A multicenter study of type 2 diabetes in Brazil. The Review of Diabetic Studies. 2006, 3: 73-78.
25.
go back to reference Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT, Howard WJ: LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. Arterioscler Thromb Vasc Biol. 2000, 20: 380-385.CrossRef Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT, Howard WJ: LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. Arterioscler Thromb Vasc Biol. 2000, 20: 380-385.CrossRef
26.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth : Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trail. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed Stamler J, Vaccaro O, Neaton JD, Wentworth : Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trail. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed
27.
go back to reference The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005, 353: 2643-2653. 10.1056/NEJMoa052187.CrossRef The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005, 353: 2643-2653. 10.1056/NEJMoa052187.CrossRef
28.
go back to reference Stratton IM, Adler AI, Neil AW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR, On behalf of the UK Prospective Diabetes Study Group: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321: 405-412. 10.1136/bmj.321.7258.405.PubMedCentralCrossRefPubMed Stratton IM, Adler AI, Neil AW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR, On behalf of the UK Prospective Diabetes Study Group: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321: 405-412. 10.1136/bmj.321.7258.405.PubMedCentralCrossRefPubMed
29.
go back to reference Stettler C, Allemann S, Juni P, Cull CA, Holman RR, Egger M, Krahenbuhl S, Diem P: Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J. 2006, 152: 27-38. 10.1016/j.ahj.2005.09.015.CrossRefPubMed Stettler C, Allemann S, Juni P, Cull CA, Holman RR, Egger M, Krahenbuhl S, Diem P: Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J. 2006, 152: 27-38. 10.1016/j.ahj.2005.09.015.CrossRefPubMed
30.
go back to reference Action to Control Cardiovascualr Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Golf DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedwald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358: 2545-2559. 10.1056/NEJMoa0802743.CrossRef Action to Control Cardiovascualr Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Golf DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedwald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358: 2545-2559. 10.1056/NEJMoa0802743.CrossRef
31.
go back to reference ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572. 10.1056/NEJMoa0802987.CrossRef ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572. 10.1056/NEJMoa0802987.CrossRef
32.
go back to reference Duckworth W, Abraira C, Moritz T, Reda D, Emannele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vikek ME, Henderson WG, Huang GD: Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med. 2009, 360: 129-139. 10.1056/NEJMoa0808431.CrossRefPubMed Duckworth W, Abraira C, Moritz T, Reda D, Emannele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vikek ME, Henderson WG, Huang GD: Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med. 2009, 360: 129-139. 10.1056/NEJMoa0808431.CrossRefPubMed
33.
go back to reference Gæde P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008, 358: 580-591. 10.1056/NEJMoa0706245.CrossRefPubMed Gæde P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008, 358: 580-591. 10.1056/NEJMoa0706245.CrossRefPubMed
Metadata
Title
Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil
Authors
Marilia B Gomes
Daniel Giannella-Neto
Manuel Faria
Marcos Tambascia
Reine M Fonseca
Rosangela Rea
Geisa Macedo
João Modesto-Filho
Helena Schmid
Alcina V Bittencourt
Saulo Cavalcanti
Nelson Rassi
Hermelinda Pedrosa
Sergio A Dib
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2009
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-1-22

Other articles of this Issue 1/2009

Diabetology & Metabolic Syndrome 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.